Shukla Sath
- SEC CIK
- 0001782817
No open-market purchases or sales filed in the past year.
Current role at each company
- SPRO Spero Therapeutics, Inc.CEO & Presidentas of Feb 5, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Shukla Sath as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 (view filing) | Feb 5 | Same day | Shukla SathCEO & President | SSale | −155.3K | $0.78 | −$121.2K | −8.2%1.74M after | 3 lots |
| Aug 29, 2024 (view filing) | Aug 27 | 2 days | Shukla SathCEO & President | SSale | −2.76K | $1.35 | −$3.72K | −0.2%1.14M after | |
| Aug 6, 2024 (view filing) | Aug 2-5 | 4 days | Shukla SathCEO and President | SSale | −32.4K | $1.31 | −$42.6K | −2.8%1.14M after | 2 lots |
| Feb 5, 2024 (view filing) | Feb 2-5 | 3 days | Shukla SathCEO and President | SSale | −76.0K | $1.42 | −$107.7K | −6.1%1.18M after | 2 lots10b5-1 |
| Aug 30, 2023 (view filing) | Aug 28-29 | 2 days | Shukla SathCEO and President | SSale | −6.02K | $1.29 | −$7.75K | −1.0%572.5K after | 2 lots10b5-1 |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Shukla SathChief Financial Officer | SSale | −9.50K | $1.83 | −$17.4K | −3.0%312.5K after | |
| Aug 30, 2022 (view filing) | Aug 29 | 1 day | Shukla SathChief Financial Officer | SSale | −6.02K | $0.89 | −$5.36K | −9.7%56.1K after |